Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
01/2001
01/02/2001US6168790 Use of antibodies to block the effects of gram-positive bacteria and mycobacteria
01/02/2001US6168787 Pluripotent vaccine against enveloped viruses
01/02/2001US6168786 Chimeric protein containing a protein of parainfluenza virus (piv-3) and a protein of respiratory syncytial virus (rsv); capable of protecting infants and similar susceptible individuals against diseases caused by both piv and rsv
01/02/2001US6168783 Antagonists of interleukin-15
01/02/2001US6168587 Needleless syringe using supersonic gas flow for particle delivery
01/02/2001CA2019218C Magnetic protein conjugates, a process for the preparation thereof and the use thereof
12/2000
12/29/2000CA2300467A1 Cancer vaccines
12/28/2000WO2000079010A1 Compositions and methods for preventing transepithelial transmission of hiv
12/28/2000WO2000078972A2 Regulation with binding cassette transporter protein abc1
12/28/2000WO2000078971A2 Atp binding cassette transporter protein abc1 popypeptides
12/28/2000WO2000078969A1 Hiv tat peptides and multiple peptide conjugate system
12/28/2000WO2000078966A1 Groups of borrelia burgdorferi and borrelia afzelii that cause lyme disease in humans
12/28/2000WO2000078960A2 Compositions and methods for the therapy and diagnosis of breast cancer
12/28/2000WO2000078954A2 Human transcriptional regulator proteins
12/28/2000WO2000078952A2 Human rna metabolism proteins (rmep)
12/28/2000WO2000078941A2 Methods and products for manipulating uncoupling protein expression
12/28/2000WO2000078924A1 Method for the preservation of biologically-active material
12/28/2000WO2000078815A1 ANTI-αvβ3? RECOMBINANT HUMAN ANTIBODIES, NUCLEIC ACIDS ENCODING SAME AND METHODS OF USE
12/28/2000WO2000078802A2 Secreted polypeptides and corresponding polynucleotides
12/28/2000WO2000078800A2 Combined decorin binding protein and outer surface protein compositions and methods of use
12/28/2000WO2000078790A2 Methods for inhibiting hiv replication
12/28/2000WO2000078787A1 ISOLATED GENES FROM VIRULENT GROUP B $i(STREPTOCOCCUS AGALACTIAE)
12/28/2000WO2000078360A1 Compositions and methods for the treatment or prevention of autoimmune disorders
12/28/2000WO2000078353A2 Aqueous immunologic adjuvant compositions of monophosphoryl lipid a
12/28/2000WO2000078348A1 Autologous adoptive immunotherapy with primed antigen-specific t cells or b cells
12/28/2000WO2000078347A1 Cell growth inhibition
12/28/2000WO2000078346A1 Novel anti-allergic agents
12/28/2000WO2000078345A1 Method for treatment of lyme disease
12/28/2000WO2000078344A1 Prion protein peptides and uses thereof
12/28/2000WO2000078343A2 Method for treating chronic hbv infection
12/28/2000WO2000078342A1 Compositions and methods for the prevention, treatment and detection of tuberculosis and other diseases
12/28/2000WO2000078337A1 Compositions containing soluble forms of hla-g for treating inflammatory skin pathologies
12/28/2000WO2000078334A1 Chimeric chemokine-antigen polypeptides and uses therefor
12/28/2000WO2000058460A3 Casb619 involved in colon cancers
12/28/2000WO2000053767A3 Nucleic acid respiratory syncytial virus vaccines
12/28/2000WO2000050074A3 Neisserial vaccine compositions and methods
12/28/2000WO2000048625A3 Inhibitors for use in hemostasis and immune function
12/28/2000WO2000048614A3 Method for producing anti-tumor th1 cells
12/28/2000WO2000046344A3 Non-stochastic generation of genetic vaccines and enzymes
12/28/2000WO2000045851A3 Preparation for the prevention and/or treatment of a tissue change of mesenchymal origin
12/28/2000WO2000037640A3 Compositions and methods for the treatment of tumor
12/28/2000WO2000034474A3 Growth factor homolog zvegf3
12/28/2000WO2000032776A3 Secreted amd transmembrane polypeptides and nucleic acids encoding the same
12/28/2000WO2000030667A3 Compositions and methods using lactadherin or variants thereof
12/28/2000CA2377648A1 Prion protein peptides and uses thereof
12/28/2000CA2377530A1 Compositions and methods for the treatment or prevention of autoimmune disorders
12/28/2000CA2377524A1 Novel anti-allergic agents
12/28/2000CA2377263A1 Polynucleotides and polypeptides encoded thereby
12/28/2000CA2376829A1 Aqueous immunologic adjuvant compositions of monophosphoryl lipid a
12/28/2000CA2376723A1 Compositions and methods for the prevention, treatment and detection of tuberculosis and other diseases
12/28/2000CA2375781A1 Compositions and methods for increasing cholesterol efflux and raising hdl using atp binding cassette transporter protein abci
12/28/2000CA2375508A1 Methods and products for manipulating uncoupling protein expression
12/28/2000CA2375414A1 Human transcriptional regulator proteins
12/28/2000CA2375407A1 Rna metabolism proteins
12/28/2000CA2375236A1 Anti-alphavbeta3 recombinant human antibodies, nucleic acids encoding same and methods of use
12/27/2000EP1063293A2 Transforming growth factor alpha H1
12/27/2000EP1063292A2 DNA encoding human alpha 1 adrenergic receptors and uses thereof
12/27/2000EP1063291A2 DNA encoding human alpha 1 adrenergic receptors and uses thereof
12/27/2000EP1062517A2 Diagnosis of spongiform encephalopathies using prionins
12/27/2000EP1062514A2 C-myc coding region determinant-binding protein (crd-bp)
12/27/2000EP1062509A2 Methods and compositions for diagnosis of rheumatoid arthritis
12/27/2000EP1062347A1 Diagnostics and vaccines for mycobacterial infections of animals and humans
12/27/2000EP1062341A1 Mutant recombinant allergens
12/27/2000EP1062335A1 Breast cancer antigen
12/27/2000EP1062332A2 Human receptor proteins; related reagents and methods
12/27/2000EP1062331A1 Compounds related to pap-1
12/27/2000EP1062325A2 Purification of virus preparations
12/27/2000EP1062324A2 Medium and method for viral propagation and growth
12/27/2000EP1062320A1 Methods and compositions for the selective expansion of gamma/delta t-cells
12/27/2000EP1062246A1 Anti-inositolphosphoglycan monoclonal antibodies
12/27/2000EP1062245A1 Products comprising inactivated yeasts or moulds and active vhh-type antibodies
12/27/2000EP1062225A1 REPLICATIVE HELICASE dnaB OF $i(STAPHYLOCOCCUS AUREUS)
12/27/2000EP1061959A2 Radioimmuno-pharmacon for treating the hiv-1 infection
12/27/2000EP1061951A1 Use of skin penetration enhancers and barrier disruption agents to enhance the transcutaneous immune response induced by adp-ribosylating exotoxin
12/27/2000EP1061950A1 Live vaccine for human immunodeficiency virus
12/27/2000EP1061949A1 Use of cytokines and mitogens to inhibit graft versus host disease
12/27/2000EP1061905A2 Methods and compositions for detection and diagnosis of infectious diseases
12/27/2000EP1061903A1 Delivery system to modulate immune response
12/27/2000EP1061902A1 Colonic delivery of protein or peptide compositions
12/27/2000EP0804483B1 Isolated peptides derived from mage tumor rejection antigen precursors which complex with hla-a2 molecules
12/27/2000EP0791065B1 Protein targeting into hiv virions based on hiv-1 vpr fusion molecules
12/27/2000EP0554319B1 Antimicrobial composition
12/27/2000CN1278301A Procine circoviruses, vaccines and diagnostic reagents
12/27/2000CN1278300A Multivalent antigen-binding proteins
12/27/2000CN1278185A Compact epstein-barr virus peplicons
12/27/2000CN1059927C Reconstituted hepatitis B vaccine with corboxy and having anterior surface antigen 1 determinant
12/27/2000CN1059836C Production of inactivated vaccine for epidemic hemorrhagic fever using primary cells of kidney of golden yellow hamster
12/26/2000US6166193 Nucleotide sequence which encodes g-protein coupled receptor; for the treatment and prevention of bacterial, fungal, protozoan and viral infections; for use in gene therapy
12/26/2000US6166192 PGC-1, a novel brown fat PPARγ coactivator
12/26/2000US6166185 Antibodies to human TIE-2 ligands
12/26/2000US6166182 Polypeptides for the treatment of bacterial, fungal, protozoan and viral infections
12/26/2000US6166178 Polypeptide for the treatment of cancer; anticarcinogenic agents
12/26/2000US6166177 Compounds and methods for the treatment and diagnosis of chlamydial infection
12/26/2000US6166090 Prevention atherosclerosis; administering transforming growth factor
12/26/2000US6165995 Cyclodextrin derivative in oil and water emulsion, said derivative substituted by at least one but no more than n-1 alkylacyl and alkenylacyl groups of linear hydrocarbon chains of at least eight carbon atoms and one sulfate group
12/26/2000US6165993 DNA vaccines against rotavirus infections
12/26/2000US6165992 Histidine kinase
12/26/2000US6165991 A polynucleotide, or the full complement of the entire length of the polynucleotide, which encodes the same mature polypeptide, expressed by histidine kinase encoded by a specific polynucleotide contained in streptococcus pneumoniae
12/26/2000US6165989 An isolated polynucleotide comprising a first polynucleotide or the full complement of the entire length of the first polynucleotide, wherein the first polynucleotide encodes a polypeptide comprising specific amino acid sequence
12/26/2000US6165774 Culturing virus in cells, separating out virus, solubilizing hemagglutinin-neuramidase and fusion envelope glycoproteins from virus, and coisolating and copurifying using ion exchange chromatography and hydroxyapatite matrix
1 ... 1441 1442 1443 1444 1445 1446 1447 1448 1449 1450 1451 1452 1453 1454 1455 1456 1457 1458 1459 1460 1461 ... 1823